transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
, e.g., supermarket, food and restaurants (only for takeaway), drug stores. Online sales continued to grow remarkably by 150.0% YoY. Gross profit margin from sale of goods improved outstandingly to
provinces, and 1 project overseas), 30 food centers, 7 office towers, 2 hotel properties, 12 residential project for sale comprise 9 high- rise residential projects and 3 low-rise residential projects. Table
7.46% compared to last year. The change was also inline with a rise of sales whereas the gross profit margin of this six month- period ended June 30, 2019 tend to have a good potential of 21.20% while
September 30, 2019, the Company and its subsidiary had a rise in cost of sales of goods by 6.14%. The change was also in line with a 5.01% rise of sales. One more reason is from the lessen in screw flight’s